TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 4 | 2 | 6 | 10 | 12 | 18 | 24 | 12 |
| P | %wins | 100 | 100 | 100 | 75 | 67 | 100 | 90 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/17 10:53 | 1/26/17 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldini Lawrence | OH | O | EVP,P Gl | P | 51 | 12.70 | 8 | 4 | 4 | 107 | D | -22 | -29 | -35 | -23 | -30 | -28 | -25 | -23 | 2 | 1 | 2 | 18 | ||
11/7/16 12:50 | 11/3/16 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldini Lawrence | OH | O | EVP,P Gl | P | 78 | 16.00 | 5 | 5 | 5 | 96 | D | -6 | -16 | -15 | -17 | -18 | -13 | -4 | -1 | 1 | 8 | 12 | -20 | -7 | |
12/5/12 17:06 | 12/4/12 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldini Lawrence | OH | O | EVP,Oper | P | 652 | 20.07 | 4 | 33 | 87 | 70 | D | -2 | 12 | 9 | 16 | 9 | 6 | 0 | 2 | 0 | 1 | 4 | 7 | 6 | 21 |
4/21/09 10:46 | 4/17/09 | VIVO | Meridian Bioscience Inc | OH | Health | Diagn | In Vitro & In Vivo Diagnostic | Baldini Lawrence | OH | O | EVP,Oper | P | 154 | 15.38 | 10 | 10 | 66 | 25 | D | -17 | -40 | -33 | -24 | -6 | -10 | -7 | -8 | 3 | 13 | 23 | 42 | 55 | 26 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |